CLINICAL TRIALS PROFILE FOR CYTISINICLINE
✉ Email this page to a colleague
Clinical Trials for Cytisinicline
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT03848208 ↗ | A Single Dose-escalation Study of Cytisine in Adult Smokers | Completed | Achieve Life Sciences | Phase 1 | The objectives of this study are: 1. To assess the tolerability and safety of cytisine as a single oral dose. 2. To define the Cmax levels associated to the occurrence of dose-limiting adverse events. |
NCT04576949 ↗ | A Study of Cytisinicline for Smoking Cessation in Adult Smokers | Active, not recruiting | Achieve Life Sciences | Phase 3 | This placebo-controlled Phase 3 study is being conducted at sites within the United States to evaluate 3 mg cytisinicline TID for treatment duration of 42 days/6 weeks as well as repeating that duration for a total of 84 days/12 weeks treatment. |
NCT05206370 ↗ | A Second Study of Cytisinicline for Smoking Cessation in Adult Smokers | Not yet recruiting | Achieve Life Sciences | Phase 3 | This placebo-controlled Phase 3 study is being conducted at sites within the United States to evaluate 3 mg cytisinicline TID for treatment duration of 42 days/6 weeks as well as repeating that duration for a total of 84 days/12 weeks treatment. |
NCT05431387 ↗ | A Study of Cytisinicline for Vaping Cessation in Adult Smokers | Not yet recruiting | Achieve Life Sciences | Phase 2 | This placebo-controlled Phase 2 study is being conducted at sites within the United States to evaluate the safety profile of 3 mg cytisinicline administered TID for 12 weeks. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Cytisinicline
Condition Name
Clinical Trial Locations for Cytisinicline
Trials by Country
Clinical Trial Progress for Cytisinicline
Clinical Trial Phase
Clinical Trial Sponsors for Cytisinicline
Sponsor Name